{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:00:09Z","timestamp":1790125209971,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2021R1F1A1063321"],"award-info":[{"award-number":["NRF-2021R1F1A1063321"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177836","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:07:02Z","timestamp":1749812822000},"page":"177836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LSI312A modulates myeloid-derived suppressor cell-mediated immunosuppression via NLRP3 inflammasome inhibition"],"prefix":"10.1016","volume":"1002","author":[{"given":"Chaelin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-712X","authenticated-orcid":false,"given":"Inmoo","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177836_bib1","series-title":"Homoisoflavonoids: Occurrence, Biosynthesis, and Biological Activity","author":"Castelli","year":"2017"},{"key":"10.1016\/j.ejphar.2025.177836_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2022.07.006","article-title":"Impact of nitric oxide in liver cancer microenvironment","volume":"128","author":"Dios-Barbeito","year":"2022","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2025.177836_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2025.177836_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.177836_bib5","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.humimm.2014.09.025","article-title":"Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients","volume":"75","author":"Jiang","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.177836_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030561","article-title":"Myeloid-derived suppressor cells as a therapeutic target for cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177836_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21081058","article-title":"Synthesis of natural homoisoflavonoids having either 5,7-Dihydroxy-6-methoxy or 7-Hydroxy-5,6-dimethoxy groups","volume":"21","author":"Lee","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177836_bib10","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3389\/fimmu.2018.02849","article-title":"Roles of myeloid-derived suppressor cell subpopulations in autoimmune arthritis","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejphar.2025.177836_bib12","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.7150\/ijbs.70013","article-title":"Suppressing MDSC infiltration in tumor microenvironment serves as an option for treating ovarian cancer metastasis","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.177836_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2025.177836_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14970-0","article-title":"Nitric oxide mediated inhibition of antigen presentation from DCs to CD4(+) T cells in cancer and measurement of STAT1 nitration","volume":"7","author":"Markowitz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177836_bib15","doi-asserted-by":"crossref","first-page":"17111","DOI":"10.1073\/pnas.1108121108","article-title":"Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model","volume":"108","author":"Meyer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.177836_bib16","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889075","article-title":"Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression","volume":"13","author":"Papafragkos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer Cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.177836_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fimmu.2019.00327","article-title":"Myeloid-derived suppressor cells in sepsis","volume":"10","author":"Schrijver","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.177836_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejphar.2025.177836_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.990463","article-title":"Immunotherapy of targeting MDSCs in tumor microenvironment","volume":"13","author":"Sui","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2025.177836_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.177836_bib26","first-page":"55","article-title":"Signaling pathways involved in MDSC regulation","volume":"1846","author":"Trikha","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.177836_bib27","article-title":"The role of Myeloid-Derived suppressor cells (MDSC) in cancer progression","volume":"4","author":"Umansky","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ejphar.2025.177836_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","article-title":"CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein","volume":"249","author":"Wright","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177836_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cytogfr.2022.07.007","article-title":"MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets","volume":"69","author":"Zhang","year":"2023","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:30:05Z","timestamp":1778877005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S0014299925005904"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177836","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LSI312A modulates myeloid-derived suppressor cell-mediated immunosuppression via NLRP3 inflammasome inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177836"}}